Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Add filters

Document Type
Year range
PLoS Global Public Health ; 2(6), 2022.
Article in English | CAB Abstracts | ID: covidwho-2021490


The COVID-19 pandemic has placed the use of evidence for policy-making high up on the international agenda. To fight the pandemic, Governments around the world have publicly stressed the need to draw on evidence by engaging scientific advisors and advisory bodies [1]. Furthermore, the increased demand for evidence has led to a global push for innovative solutions such as the scaling-up of living evidence syntheses [2]. At the same time, COVID-19 revealed fatal structural and systemic weaknesses in the production and use of evidence-flaws which have cost lives [3]. In many cases, institutional mechanisms and capacities to systematically mobilize and contextualize the best available evidence for rapid decision-making were missing [4]. As a consequence, policy-makers, practitioners and citizens alike were confronted with a deluge of competing claims and misinformation, severely limiting suitable decisionmaking and taking action [5]. The related surge of vaccine hesitancy has disproportionally impacted ethnic minorities and deprived communities, with the lowest vaccine uptake, worryingly, to be seen among the most vulnerable people-the older, the more clinically vulnerable, and those living in the most deprived areas-worsening pre-existing disparities in vaccine use, health inequalities and socio-economic marginalization [6, 7]. To assess different institutional responses in terms of the evidence-policy-society nexus and to learn lessons on how to build equity-centred, agile and responsive evidence-informed decision- making mechanisms, WHO convened its first Global Evidence-to-Policy Summit [8] in late 2021. The Summit, organized by the newly created Evidence to Policy Unit at WHO headquarters in collaboration with the corresponding teams in WHO regional offices, brought together more than 2,500 policy-makers, knowledge brokers, health actors, civil society representatives and researchers from around the world.

Documentos - Embrapa Solos|2021. (229):29 pp. ; 2021.
Article in English | CAB Abstracts | ID: covidwho-1777243


Brazil is a diverse country and the world's leading exporter of a number of agricultural commodities. Its agribusiness sector is performing an important role during the COVID19 pandemic. Data from the General Register of Employed and Unemployed (CAGED), released by the Ministry of Economy's Secretariat of Labor, reveal that agriculture is the only sector of Brazilian economic activity with positive results in terms of job creation in 2020. Moreover, despite the restrictions imposed by the crisis resulting from the COVID19 pandemic, the Brazilian Federal Government announced a 6% increase in the volume of resources for the 2020/2021 harvest, prioritizing investments for small and medium producers, financing the National Program for Strengthening Family Agriculture, with interest of 2.75% and 4% per year, for funding and marketing. Notwithstanding these developments, we argue that the high performance of the agricultural sector in Brazil and its diversity could help reduce the impacts of the COVID19 on the achievement of the SDGs by strengthening and encouraging sustainable agricultural initiatives. Thus, this document aims to present an overview about how some sustainable agricultural practices, already adopted in Brazil, have the potential to reduce the trade offs imposed by the COVID19 crisis and contribute to achieving the SDG targets. With the aim of supporting Brazilian agriculture during the pandemic, hot topics, like soil erosion and deforestation, must be addressed in new ways. This study meets the following Sustainable Development Goals stipulated by the United Nations (UN): SDG 2 Zero Hunger, SDG 3 Good Health and Well Being, SDG 6 Clean Water and Sanitation, SDG 13 Climate Action and SDG 15 Life on Land.